The reduction of cardiovascular morbidity and the prevention of premature mortality constitute the therapeutic cornerstones in the management of type 2 diabetes mellitus. While conventional clinical approaches have historically prioritized the optimization of anthropometric parameters and lipid profiles, contempo...
Eric Barlandas-Rendón, David Emmanuel Zacarias-Huerta, S. Quintana-Ponce et al.· Clinical Chemistry· 0 citations
Diabetic nephropathy is a complication of type 2 diabetes mellitus associated with reduced glomerular filtration rate and increased albuminuria. The Kidney Disease, Improving Global Outcomes (KDIGO) 2012 classification integrates estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) to...
Eric Barlandas-Rendón, Eduardo Vera-Vivanco, S. Quintana-Ponce et al.· Clinical Chemistry· 0 citations
Type 2 diabetes mellitus (T2DM) significantly increases cardiovascular risk (CVR). However, the burden of cardiovascular risk factors (CVRFs) and their clinical impact vary critically according to sex, requiring differentiated diagnostic approaches in laboratory medicine. The objective of this study was to evalua...
Eric Barlandas-Rendón, Gloria Abigail Pelaez-Rosas, S. Quintana-Ponce et al.· Clinical Chemistry· 0 citations
Antimicrobial resistance (AMR) in Gram-negative bacteria represents one of the major threats to global public health, particularly due to the emergence and dissemination of carbapenem-resistant microorganisms. In Mexico, longitudinal local surveillance integrating phenotypic resistance patterns and the detection...
S. Quintana-Ponce, Mario Leyva-Flores, E. Garza-González et al.· Clinical Chemistry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
